Last updated on December 2017

Uterine Fibroids Study

Brief description of study

To determine the benefit of relugolix 40 mg once daily co-administered with low dose estradiol and norethindrone acetate compared with placebo for 24 weeks on heavy menstrual bleeding associated with uterine fibroids

Clinical Study Identifier: TX155352

Find a site near you

Start Over

Clinical Trials Management, LLC

3801 Houma Blvd., Suite 200 Metairie, LA USA
  Connect »